Buscar
Mostrando ítems 41-50 de 2888
Cytokines profile and clinical-metabolic alterations in HIV-1-infected individuals with and without lypodistrophy
(2006-04-26)
Highly active antiretroviral therapy (HAART) has lead to a dramatic decrease in the morbidity of patients infected with HIV. However, metabolic side effects, including lipodystrophy and dyslipidemia, have been reported in ...
Role of upper endoscopy in diagnosing opportunistic infections in human immunodeficiency virus-infected patients
(W J G PRESS, 2009)
Highly active antiretroviral therapy (HAART) has dramatically decreased opportunistic infections (OIs) in human immunodeficiency virus (HIV)-infected patients. However, gastrointestinal disease continues to account for a ...
Visceral leishmaniasis caused by Leishmania (Viannia) braziliensis in a patient infected with human immunodeficiency virus
(Instituto de Medicina Tropical, 2019)
Early T follicular helper cell responses and germinal center reactions are associated with viremia control in immunized rhesus macaques
(American Society for Microbiology, 2019)
T follicular helper (T FH ) cells are fundamental in germinal center (GC) maturation and selection of antigen-specific B cells within secondary lymphoid organs. GC-resident T FH cells have been fully characterized in human ...
Amino Acid Substitutions at Position 190 of Human Immunodeficiency Virus Type 1 Reverse Transcriptase Increase Susceptibility to Delavirdine and Impair Virus Replication
(American Society for Microbiology, 2003-01)
Suboptimal treatment of human immunodeficiency virus type 1 (HIV-1) infection with nonnucleoside reverse transcriptase inhibitors (NNRTI) often results in the rapid selection of drug-resistant virus. Several amino acid ...
Syphilis, Leprosy, and Human Immunodeficiency Virus Coinfection: A Challenging Diagnosis
(Quadrant Health Com In, 2016)
Seroepidemiological study of herpes simplex virus type 2 in patients with the acquired immunodeficiency syndrome in the city of Niterói, Rio de Janeiro, Brazil
(Fundação Oswaldo Cruz. Instituto Oswaldo Cruz, 2019)
Treatment of human papillomavirus with peg-interferon alfa-2b and ribavirin
(ContextoSalvadorBrasil, 2007)